TELA Bio TELA
NASDAQ TELA
$0.63 -0.01 (-2.23%)
As of: Aug 20, 2026 · 3:59 PM EDT

TELA Bio (TELA) Change in Acquisitions & Divestments (2020)

TELA Bio (TELA) posted quarterly Change in Acquisitions & Divestments of $5.3 million for Q2 2020, up 32.22% quarter-over-quarter from $4.0 million in Q1 2020.

TELA Bio (TELA) Change in Acquisitions & Divestments (2020) Analysis & Trends

TELA Bio's Change in Acquisitions & Divestments history runs 1 years deep, the most recent figure standing at $5.3 million for Q2 2020.

  • In Q2 2020, Change in Acquisitions & Divestments changed N/A year-over-year to $5.3 million; the TTM figure through Dec 2020 stood at $9.3 million (changed N/A YoY), while the FY2020 annual figure was $9.3 million, changed N/A from the prior year.
  • Change in Acquisitions & Divestments for Q2 2020 stood at $5.3 million, up from $4.0 million in the prior quarter.
  • The five-year high for Change in Acquisitions & Divestments was $5.3 million in Q2 2020, with the low at $4.0 million in Q1 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn
10 TELA Bio 36.34 Mn 5.92 Mn 13.94 Mn

Historic Data

Download Data
DateValue
Jun 30, 2020 5.29 Mn
Jun 30, 2020 5.29 Mn
Mar 31, 2020 4.00 Mn
Mar 31, 2020 4.00 Mn